Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013:110:49-71.
doi: 10.1016/B978-0-12-410502-7.00003-X.

Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes

Manju A Kurian  1 , Susan J Hayflick
Affiliations
Review

Pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN): review of two major neurodegeneration with brain iron accumulation (NBIA) phenotypes

Manju A Kurian et al. Int Rev Neurobiol. 2013.

Abstract

Neurodegeneration with brain iron accumulation (NBIA) comprises a heterogeneous group of disorders characterized by the presence of radiologically discernible high brain iron, particularly within the basal ganglia. A number of childhood NBIA syndromes are described, of which two of the major subtypes are pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN). PKAN and PLAN are autosomal recessive NBIA disorders due to mutations in PANK2 and PLA2G6, respectively. Presentation is usually in childhood, with features of neurological regression and motor dysfunction. In both PKAN and PLAN, a number of classical and atypical phenotypes are reported. In this chapter, we describe the clinical, radiological, and genetic features of these two disorders and also discuss the pathophysiological mechanisms postulated to play a role in disease pathogenesis.

Keywords: Neurodegeneration with brain iron accumulation (NBIA); PANK2; PLA2G6.

PubMed Disclaimer

Figures

Figure 2.1
Figure 2.1
Radiological features of PKAN on brain MRI. Axial T2 (A) and axial FLAIR (B) images indicating the “eye-of-the-tiger” sign with medial globus pallidus hyperintensity (yellow arrow) surrounded by a region of hypointensity (blue arrow).
Figure 2.2
Figure 2.2
PLA2G6 and PANK2 enzymes: biochemical pathway and implicated cellular processes in PLAN and PKAN.
Figure 2.3
Figure 2.3
Radiological features of PLAN on brain MRI. Sagittal T1-weighted sequence (A) showing abnormal orientation of the posterior splenium of the corpus callosum (blue arrow), apparent claval hypertrophy (yellow arrow), and marked atrophy of the cerebellum (white arrow). T2-weighted sequences showing hypointensity in the globus pallidus (B) and substantia nigra (C), both indicated by yellow arrows. Note symmetrical white matter changes are evident on images (B) and (C), which can be reported in PLAN.
See this image and copyright information in PMC

References

    1. Abbruzzese G, Cossu G, Balocco M, Marchese R, Murgia D, Melis M, et al. A pilot trial of deferiprone for neurodegeneration with brain iron accumulation. Haematologica. 2011;96:1708–1711. - PMC - PubMed
    1. Baburina I, Jackowski S. Cellular responses to excess phospholipid. Journal of Biological Chemistry. 1999;274:9400–9408. - PubMed
    1. Balsinde J, Balboa MA. Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells. Cellular Signalling. 2005;17:1052–1062. - PubMed
    1. Baumeister FA, Auer DP, Hortnagel K, Freisinger P, Meitinger T. The eye-of-the-tiger sign is not a reliable disease marker for Hallervorden–Spatz syndrome. New England Journal of Medicine. 2005;348:33–40. - PubMed
    1. Benke T, Butterworth B. Palilalia and repetitive speech: Two case studies. Brain and Language. 2001;78:62–81. - PubMed

Publication types

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources